This image is a representation. Your design will be featured in the final product. 
Claims
- Reduction in rhinorrhoea within 6 days.
- Improvement in nasal congestion within the first 30 minutes.
- Reduction in headaches from the third day.
- Reduction in facial pain from the third day.
- Reduced use of antibiotics.
Mode of action
- Protective Barrier: It forms a thin, protective film over the mucosa, creating a mechanical barrier that shields it from direct contact with external agressors such as pathogens and environmental factors that can prolong or exacerbate rhinosinutis.
- Mechanical Cleaning: Utilizes osmotic activity to draw out fluids and irritants, cleansing the nasal mucosa, reducing swelling, and alleviating nasal congestion, indirectly addressing inflammation.
- Cellular Repair: Promotes healing and regeneration of the mucosa for sustained relief.
Clinical Trial
The effectiveness of NESOSPRAY HE has been evaluated in a randomized, double-blind clinical trial against a placebo, conducted. The trial included patients with rhinosinusitis, encompassing all symptoms related to this condition.
TYPE OF TRIAL: Randomized, double-blind clinical trial against placebo | 14 days
PATIENTS: N=54 | Test product = 38 ; Comparator = 16
Main results
NASAL CONGESTION
- 34 % reduction in nasal congestion within 30 min
- 48 % reduction in nasal congestion within 3 days
- 58% reduction in nasal congestion within 6 days
RHINORRHEA
- 36% augmentation in rhinorrhea within 30 min (because the product strongly increases nasal secretions after application)
- 33% reduction in rhinorrhea within 6 days (due to the healing and repair of the mucosa)
- 77% reduction in rhinorrhea within 14 days
OTHER PARAMETERS
- 64% reduction in headache within 3 days
- 66% reduction in facial pain within 3 days
- 26% reduction in postnasal drip within 3 days
- Rescue antibiotics score : 19 % for placebo group vs 3 % for test group
- Improvement of the quality of life
Product Details
- Indication: Used in adults for the treatment of acute rhinosinusitis and rhinopharyngitis.
- Composition: Glycerol, HPC, Aqua EO: Mentha, Eucalypt, Thym, and Rosemary.
- Presentation: Nasal spray 15ml.
- Class: MDR Class IIa.
- Direction: Apply 3 sprays in each nostril, 4 times a day. Treatment duration : 14 days.
- Precautions: For topical use only (nasal cavity). Keep out of reach and sight of children.
- Exclusions: The product should not be used in certain cases: if you have a disease that could compromise breathing, such as bronchopneumonia; if you have had recent nasal surgery; if you have evidence of immunosuppression; if you have abnormal structural narrowing of the sinus passages, such as a deviated septum or any other anatomical obstruction; or if you suffer from chronic rhinosinusitis, with or without nasal polyps, pregnant or breastfeeding women.
- Age: 18+.
- Storage conditions: Below 25°C.
- Legal manufacturer: VITROBIO (France).
- Product code: NHE.